Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Cong Xin Huang"'
Publikováno v:
Heliyon, Vol 9, Iss 10, Pp e20805- (2023)
Aims: To investigate the effects of M-CSF on myocardial injury in mice after MI by regulating different types of cardiac macrophages through the P2X7R/NLRP3/IL-1β signal pathway. Methods: A total of 60 C57BL/6J WT mice were used, with the Sham Group
Externí odkaz:
https://doaj.org/article/6193592f8ee047d987fd770a18de5888
Autor:
Lin Yin, Feng-yuan Wang, Wei Zhang, Xi Wang, Yan-hong Tang, Teng Wang, Yu-ting Chen, Cong-xin Huang
Publikováno v:
Stem Cell Research & Therapy, Vol 13, Iss 1, Pp 1-15 (2022)
Abstract Background The source of SAN is debated among researchers. Many studies have shown that RA and Wnt signaling are involved in heart development. In this study, we investigated the role of retinoic acid (RA) and Wnt signaling in the induction
Externí odkaz:
https://doaj.org/article/1cb0450c360b438fb2c3c3045768dbea
Autor:
Yan Huang, Hua-Sheng Ding, Tao Song, Yu-Ting Chen, Teng Wang, Yan-Hong Tang, Hector Barajas-Martinez, Cong-Xin Huang, Dan Hu
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Introduction: Myocardial infarction (MI) triggers structural and electrical remodeling. CC chemokine receptor 9 (CCR9) mediates chemotaxis of inflammatory cells in MI. In our previous study, CCR9 knockout has been found to improve structural remodeli
Externí odkaz:
https://doaj.org/article/9b4a6ad32a614b9a9bb5f85c151713bd
Autor:
Jin-Jun Liang, Hideo Okamura, Roshini Asirvatham, Andrew Schneider, David O. Hodge, Mei Yang, Xu-Ping Li, Ming-Yan Dai, Ying Tian, Pei Zhang, Bryan C. Cannon, Cong-Xin Huang, Paul A. Friedman, Yong-Mei Cha, Li-Shao Guo
Publikováno v:
Chinese Medical Journal, Vol 132, Iss 6, Pp 631-637 (2019)
Abstract. Background:. The comparative outcomes of subcutaneous implantable cardioverter-defibrillator (S-ICD) and transvenous ICD (T-ICD) have not been well studied. The aim of this study was to evaluate the safety and efficacy of currently availabl
Externí odkaz:
https://doaj.org/article/3a828b0bf8bd4c3d845f4a57156e466b
Autor:
Bei-Lei Liu, Mian Cheng, Shan Hu, Shun Wang, Le Wang, Zheng-Qing Hu, Cong-Xin Huang, Hong Jiang, Gang Wu
Publikováno v:
Chinese Medical Journal, Vol 131, Iss 19, Pp 2287-2296 (2018)
Background: Shensong Yangxin Capsule (SSYX), traditional Chinese medicine, has been used to treat arrhythmias, angina, cardiac remodeling, cardiac fibrosis, and so on, but its effect on cardiac energy metabolism is still not clear. The objective of t
Externí odkaz:
https://doaj.org/article/eb6de01c95b042b6b5b731799d20b66a
Autor:
Qing-Yan Zhao, Shao-Bo Shi, He Huang, Hong Jiang, Bo Yang, Gang Wu, Ming-Wei Bao, Yu Liu, Yan-Hong Tang, Xi Wang, Shu Zhang, De-Jia Huang, Yong Huo, Jun-Bo Ge, Cong-Xin Huang, Pei-Fang Wei.
Publikováno v:
Chinese Medical Journal, Vol 133, Iss 23, Pp 2883-2884 (2020)
Externí odkaz:
https://doaj.org/article/8b94001000ed4d3c9288d93206a41d84
Autor:
Hong-Yi Zhao, Shu-Di Zhang, Kai Zhang, Xi Wang, Qing-Yan Zhao, Shu-Juan Zhang, Zi-Xuan Dai, Yong-Sheng Qian, You-Jing Zhang, Hao-Tian Wei, Yan-Hong Tang, Cong-Xin Huang
Publikováno v:
Chinese Medical Journal, Vol 130, Iss 2, Pp 171-178 (2017)
Background: Shensong Yangxin (SSYX), a traditional Chinese herbal medicine, has long been used clinically to treat arrhythmias in China. However, the mechanism of SSYX on atrial fibrillation (AF) is unknown. In this study, we tested the hypothesis th
Externí odkaz:
https://doaj.org/article/ad9294dcde2f4ab2a5dee716bf437905
Autor:
Xi Wang, Dan Hu, Song Dang, He Huang, Cong-Xin Huang, Ming-Jie Yuan, Yan-Hong Tang, Qing-Shan Zheng, Fang Yin, Shu Zhang, Bo-Li Zhang, Run-Lin Gao, for the Efficacy and Safety of Shensong Yangxin Capsules for Frequent VPCs in Congestive Heart Failure Study Group
Publikováno v:
Chinese Medical Journal, Vol 130, Iss 14, Pp 1639-1647 (2017)
Background: Pharmacological therapy for congestive heart failure (CHF) with ventricular arrhythmia is limited. In the study, our aim was to evaluate the effects of Chinese traditional medicine Shensong Yangxin capsules (SSYX) on heart rhythm and func
Externí odkaz:
https://doaj.org/article/c78afea611ff471190a6edc70d36b9ab
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Background: Cardiac fibrosis after myocardial infarction mainly causes cardiac diastolic and systolic dysfunction, which results in fatal arrhythmias or even sudden death. Id2, a transcriptional repressor, has been shown to play an important role in
Externí odkaz:
https://doaj.org/article/8df59ab53c4845cda4a2c088a19ec33c
Autor:
Dan Hu, Hector Barajas-Martinez, Zhong-He Zhang, Hong-Yi Duan, Qing-Yan Zhao, Ming-Wei Bao, Yi-Mei Du, Alexander Burashnikov, Michelle M. Monasky, Carlo Pappone, Cong-Xin Huang, Charles Antzelevitch, Hong Jiang
Publikováno v:
Philosophical Transactions of the Royal Society B: Biological Sciences. 378
Atrial fibrillation (AF) is a very common cardiac arrhythmia with an estimated prevalence of 33.5 million patients globally. It is associated with an increased risk of death, stroke and peripheral embolism. Although genetic studies have identified a